RANLUSPEC FDA approval date

The FDA approved RANLUSPEC on 2 Jun 2026.

FDA approval date
2 Jun 2026

Drug identity has not yet been verified against registry records

Also recorded as RANIBIZUMAB-HKDZ

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2026-06-02DayRANLUSPECFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA761480", "applicant_as_listed_by_fda": "LUPIN LIMITED", "brand_names": ["RANLUSPEC"], "active_ingredients": ["RANIBIZUMAB-HKDZ"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20260602", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026